WO2007101935A3 - Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent - Google Patents

Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent Download PDF

Info

Publication number
WO2007101935A3
WO2007101935A3 PCT/FR2007/000384 FR2007000384W WO2007101935A3 WO 2007101935 A3 WO2007101935 A3 WO 2007101935A3 FR 2007000384 W FR2007000384 W FR 2007000384W WO 2007101935 A3 WO2007101935 A3 WO 2007101935A3
Authority
WO
WIPO (PCT)
Prior art keywords
preparation
pharmaceutical compositions
same
compositions containing
novel heterocyclic
Prior art date
Application number
PCT/FR2007/000384
Other languages
English (en)
Other versions
WO2007101935A2 (fr
Inventor
Aurelie Hurtevent
Helgoual Ch Jean-Martial L
Pascal Carato
Nicolas Lebegue
Veronique Leclerc
Naour Morgan Le
Pascal Berthelot
Catherine Dacquet
Alain Ktorza
Daniel-Henri Caignard
Original Assignee
Servier Lab
Aurelie Hurtevent
Helgoual Ch Jean-Martial L
Pascal Carato
Nicolas Lebegue
Veronique Leclerc
Naour Morgan Le
Pascal Berthelot
Catherine Dacquet
Alain Ktorza
Daniel-Henri Caignard
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Servier Lab, Aurelie Hurtevent, Helgoual Ch Jean-Martial L, Pascal Carato, Nicolas Lebegue, Veronique Leclerc, Naour Morgan Le, Pascal Berthelot, Catherine Dacquet, Alain Ktorza, Daniel-Henri Caignard filed Critical Servier Lab
Priority to BRPI0708586-9A priority Critical patent/BRPI0708586A2/pt
Priority to US12/224,861 priority patent/US20090239917A1/en
Priority to EP07731083A priority patent/EP1991537A2/fr
Priority to CA002643694A priority patent/CA2643694A1/fr
Priority to MX2008011449A priority patent/MX2008011449A/es
Priority to JP2008557793A priority patent/JP2009529026A/ja
Priority to AU2007222292A priority patent/AU2007222292A1/en
Priority to EA200801910A priority patent/EA200801910A1/ru
Publication of WO2007101935A2 publication Critical patent/WO2007101935A2/fr
Publication of WO2007101935A3 publication Critical patent/WO2007101935A3/fr
Priority to NO20083945A priority patent/NO20083945L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/428—Thiazoles condensed with carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Abstract

Composés de formule (I) dans laquelle : - R1 représente un groupement cycloalkyle (C3-C8), - R2 représente un groupement de formule (II) tel que défini dans la description, - X représente un atome d'oxygène, ou un groupement N-OR' dans lequel R' représente un atome d'hydrogène, un groupement alkyle (C1-C6) linéaire ou ramifié, aryle ou arylalkyle (C1-C6) linéaire ou ramifié, comme agents hypoglycémiants et hypolipémiants.
PCT/FR2007/000384 2006-03-06 2007-03-05 Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent WO2007101935A2 (fr)

Priority Applications (9)

Application Number Priority Date Filing Date Title
BRPI0708586-9A BRPI0708586A2 (pt) 2006-03-06 2007-03-05 derivados heterocìclicos cicloalquilas, respectivo processo de preparo e composições farmacêuticas que contêm
US12/224,861 US20090239917A1 (en) 2006-03-06 2007-03-05 Heterocyclic Cycloalkyl Compounds, a Process for their Preparation and Pharmaceutical Compositions Containing Them
EP07731083A EP1991537A2 (fr) 2006-03-06 2007-03-05 Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
CA002643694A CA2643694A1 (fr) 2006-03-06 2007-03-05 Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX2008011449A MX2008011449A (es) 2006-03-06 2007-03-05 Derivados de cicloalquilo heterociclicos novedosos, metodo para la preparacion de los mismos, y composiciones farmaceuticas que contienen los mismos.
JP2008557793A JP2009529026A (ja) 2006-03-06 2007-03-05 新規な複素環シクロアルキル誘導体、その製造法およびそれを含有する薬学的組成物
AU2007222292A AU2007222292A1 (en) 2006-03-06 2007-03-05 Novel heterocyclic cycloalkyl derivatives, method for the preparation thereof, and pharmaceutical compositions containing the same
EA200801910A EA200801910A1 (ru) 2006-03-06 2007-03-05 Новые гетероциклические циклоалкильные соединения, способ их получения и фармацевтические композиции, которые их содержат
NO20083945A NO20083945L (no) 2006-03-06 2008-09-16 Nye heterosykliske sykloalkylforbindelser, en fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0601954 2006-03-06
FR0601954A FR2898125B1 (fr) 2006-03-06 2006-03-06 Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
WO2007101935A2 WO2007101935A2 (fr) 2007-09-13
WO2007101935A3 true WO2007101935A3 (fr) 2008-02-21

Family

ID=37387383

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/FR2007/000384 WO2007101935A2 (fr) 2006-03-06 2007-03-05 Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Country Status (16)

Country Link
US (1) US20090239917A1 (fr)
EP (1) EP1991537A2 (fr)
JP (1) JP2009529026A (fr)
KR (1) KR20080099871A (fr)
CN (1) CN101395145A (fr)
AR (1) AR059749A1 (fr)
AU (1) AU2007222292A1 (fr)
BR (1) BRPI0708586A2 (fr)
CA (1) CA2643694A1 (fr)
EA (1) EA200801910A1 (fr)
FR (1) FR2898125B1 (fr)
MA (1) MA30295B1 (fr)
MX (1) MX2008011449A (fr)
NO (1) NO20083945L (fr)
TW (1) TW200745068A (fr)
WO (1) WO2007101935A2 (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101216274B1 (ko) 2011-06-17 2012-12-28 이화여자대학교 산학협력단 골다공증 완화, 예방 또는 치료효과의 신규한 화합물, 이의 제조방법 및 이를 포함하는 약학조성물

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057002A1 (fr) * 2000-02-02 2001-08-09 Les Laboratoires Servier Derives d'azoles condenses et leur utilisation comme agents hypoglycemiants
EP1502590A1 (fr) * 2003-07-28 2005-02-02 Les Laboratoires Servier Dérivés d'oximes hétérocycliques, leur procédé de préparation et leur utilisation dans le traitement du diabète de type II
WO2005099694A1 (fr) * 2004-03-31 2005-10-27 Les Laboratoires Servier Association entre un compose heterocyclique et un agent antioxydant et son utilisation pour le traitement de l’obesite

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2001057002A1 (fr) * 2000-02-02 2001-08-09 Les Laboratoires Servier Derives d'azoles condenses et leur utilisation comme agents hypoglycemiants
EP1502590A1 (fr) * 2003-07-28 2005-02-02 Les Laboratoires Servier Dérivés d'oximes hétérocycliques, leur procédé de préparation et leur utilisation dans le traitement du diabète de type II
WO2005099694A1 (fr) * 2004-03-31 2005-10-27 Les Laboratoires Servier Association entre un compose heterocyclique et un agent antioxydant et son utilisation pour le traitement de l’obesite

Also Published As

Publication number Publication date
TW200745068A (en) 2007-12-16
WO2007101935A2 (fr) 2007-09-13
NO20083945L (no) 2008-09-16
EA200801910A1 (ru) 2009-02-27
FR2898125A1 (fr) 2007-09-07
KR20080099871A (ko) 2008-11-13
AR059749A1 (es) 2008-04-23
BRPI0708586A2 (pt) 2011-06-07
MX2008011449A (es) 2008-09-24
CN101395145A (zh) 2009-03-25
MA30295B1 (fr) 2009-03-02
FR2898125B1 (fr) 2008-06-13
AU2007222292A1 (en) 2007-09-13
EP1991537A2 (fr) 2008-11-19
US20090239917A1 (en) 2009-09-24
CA2643694A1 (fr) 2007-09-13
JP2009529026A (ja) 2009-08-13

Similar Documents

Publication Publication Date Title
WO2008146871A1 (fr) Nouveau dérivé de 1,2,3,4-tétrahydroquinoxaline qui a, comme substituant, un groupe phényle dans lequel est introduite une structure d'ester d'acide sulfonique ou une structure d'amide d'acide sulfonique et qui possède une activité de liaison aux récepteurs des glucocorticoïdes
WO2008114817A1 (fr) Nouveau composé d'adénine
WO2005105732A8 (fr) Composes methylaryl- ou heteroarylamides substitues
TW200510381A (en) Novel 2-pyridinecarboxamide derivatives
TW200635509A (en) 5-Alkoxyalkyl-6-alkyl-7-aminoazolopyrimidines, process for their preparation, their use for controlling harmful fungi, and compositions comprising them
CA2565660A1 (fr) Composes aryl- ou heteroarylamides ortho-substitues
WO2008071918A8 (fr) Dérivés de pyrido-pyrazine utiles en tant que composés herbicides
EP1982982A4 (fr) Nouveau derive de coumarine ayant une activite antitumorale
TNSN07397A1 (en) Acetylene derivatives
WO2007095174A3 (fr) derives d'acides biliaires en tant que ligands de FXR pour la prevention ou le traitement de maladies ou d'etats induits par FXR
WO2009028543A1 (fr) Dérivé de pyrazole substitué
MX2007007956A (es) Nuevos derivados naftalenicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
IL189466A0 (en) Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine
TW200738667A (en) Preparation method for dioxan-2-ylalkylcarbamate derivatives and intermediate thereof
WO2007074915A8 (fr) Composé de benzoazépine soluble dans l’eau et sa composition pharmaceutique
MX2010006446A (es) Nuevos derivados de diazeniodiolato, procedimiento para la preparacion de los mismos y composiciones farmaceuticas que los contienen.
TNSN07395A1 (en) Novel phenyl-pyridinyl-piperazine derivatives, a method for the production thereof and pharmaceutical compositions containing said derivatives
NO20074346L (no) Nye heterocykliske oksimforbindelser, fremgangsmate for deres fremstilling og farmasoytiske sammensetninger inneholdende dem
PT2000473E (pt) Composto de trealose e preparação farmacêutica que contém esse composto
WO2008049997A3 (fr) Derives indoliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2006036007A3 (fr) Preparation a liberation modifiee
WO2009057733A1 (fr) Nouveau dérivé d'indole présentant une activité anti-angiogénique
WO2007101935A3 (fr) Nouveaux derives heterocycliques cycloalkyles, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
WO2008099727A1 (fr) Dérivé d'acrylate substitué en alpha et procédé de fabrication de celui-ci
IL170056A (en) Pyrazole compounds

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2007731083

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2643694

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 2007222292

Country of ref document: AU

Ref document number: PI 20083305

Country of ref document: MY

WWE Wipo information: entry into national phase

Ref document number: 7458/DELNP/2008

Country of ref document: IN

Ref document number: 2008091465

Country of ref document: EG

WWE Wipo information: entry into national phase

Ref document number: 200780007648.X

Country of ref document: CN

WWE Wipo information: entry into national phase

Ref document number: 571031

Country of ref document: NZ

WWE Wipo information: entry into national phase

Ref document number: MX/a/2008/011449

Country of ref document: MX

Ref document number: 2008557793

Country of ref document: JP

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2007222292

Country of ref document: AU

Date of ref document: 20070305

Kind code of ref document: A

WWE Wipo information: entry into national phase

Ref document number: 10923

Country of ref document: GE

Ref document number: 200801910

Country of ref document: EA

WWE Wipo information: entry into national phase

Ref document number: 12224861

Country of ref document: US

ENP Entry into the national phase

Ref document number: PI0708586

Country of ref document: BR

Kind code of ref document: A2

Effective date: 20080905